Targeting the kinase activities of ATR and ATM exhibits antitumoral activity in mouse models of MLL -rearranged AML
Author(s) -
Isabel Morgado-Palacin,
Amanda Day,
Matilde Murga,
Vanesa Lafarga,
Marta Elena Antón,
Anthony Tubbs,
Hua-Tang Chen,
Aysegul V. Ergen,
Rhonda Anderson,
Avinash Bhandoola,
Kurt G. Pike,
Bernard Barlaam,
Elaine Cadogan,
Xi Wang,
Andrew J. Pierce,
Chad Hubbard,
Scott A. Armstrong,
André Nussenzweig,
Óscar Fernández-Capetillo
Publication year - 2016
Publication title -
science signaling
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.659
H-Index - 154
eISSN - 1937-9145
pISSN - 1945-0877
DOI - 10.1126/scisignal.aad8243
Subject(s) - kinase , cancer research , leukemia , microbiology and biotechnology , biology , chemistry , medicine , genetics
Chemotherapy-resistant acute myeloid leukemia may respond to inhibition of ATR or ATM.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom